Schroder Investment Management Group raised its holdings in Masimo Co. (NASDAQ:MASI) by 38.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 468,020 shares of the medical equipment provider’s stock after purchasing an additional 129,905 shares during the period. Schroder Investment Management Group’s holdings in Masimo were worth $39,687,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. USA Mutuals Advisors Inc. purchased a new stake in shares of Masimo in the 4th quarter valued at $110,000. SeaCrest Wealth Management LLC purchased a new stake in shares of Masimo in the 4th quarter valued at $116,000. DekaBank Deutsche Girozentrale raised its holdings in shares of Masimo by 78.3% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock valued at $182,000 after buying an additional 925 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Masimo by 39.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock valued at $239,000 after buying an additional 802 shares during the period. Finally, Jane Street Group LLC purchased a new stake in shares of Masimo in the 3rd quarter valued at $317,000. Institutional investors own 82.18% of the company’s stock.
In related news, EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The stock was sold at an average price of $88.17, for a total transaction of $881,700.00. Following the completion of the transaction, the executive vice president now directly owns 75,018 shares of the company’s stock, valued at approximately $6,614,337.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $93.07, for a total value of $186,140.00. Following the transaction, the director now directly owns 68,249 shares of the company’s stock, valued at $6,351,934.43. The disclosure for this sale can be found here. Insiders have sold a total of 48,098 shares of company stock valued at $4,315,261 over the last three months. 16.60% of the stock is currently owned by insiders.
Masimo Co. (MASI) opened at $85.40 on Thursday. Masimo Co. has a one year low of $80.69 and a one year high of $104.71. The company has a market capitalization of $4,422.02, a price-to-earnings ratio of 32.79, a P/E/G ratio of 3.25 and a beta of 0.85.
TRADEMARK VIOLATION NOTICE: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://baseballnewssource.com/markets/masimo-co-masi-shares-bought-by-schroder-investment-management-group/1903515.html.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.